TY - JOUR
T1 - Macrophage Phenotype and Function in Liver Disorder
AU - Dou, Lang
AU - Shi, Xiaomin
AU - He, Xiaoshun
AU - Gao, Yifang
N1 - Funding Information:
YG was supported by the Natural Science Foundation of Guangdong Province (Grant No. 2018A030313019); National Natural Science Foundation of China (Grant No. 31800758); Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China (Grant Nos. 2013A061401007 and 2017B030314018); and Guangdong Provincial International Cooperation Base of Science and Technology (Organ Transplantation), The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China (Grant No. 2015B050501002).
Publisher Copyright:
© Copyright © 2020 Dou, Shi, He and Gao.
PY - 2019
Y1 - 2019
N2 - Hepatic macrophages are a remarkably heterogeneous population consisting of self-renewing tissue-resident phagocytes, termed Kupffer cells (KCs), and recruited macrophages derived from peritoneal cavity as well as the bone marrow. KCs are located in the liver sinusoid where they scavenge the microbe from the portal vein to maintain liver homeostasis. Liver injury may trigger hepatic recruitment of peritoneal macrophages and monocyte-derived macrophages. Studies describing macrophage accumulation have shown that hepatic macrophages are involved in the initiation and progression of various liver diseases. They act as tolerogenic antigen-presenting cells to inhibit T-cell activation by producing distinct sets of cytokines, chemokines, and mediators to maintain or resolve inflammation. Furthermore, by releasing regenerative growth factors, matrix metalloproteinase arginase, they promote tissue repair. Recent experiments found that KCs and recruited macrophages may play different roles in the development of liver disease. Given that hepatic macrophages are considerably plastic populations, their phenotypes and functions are likely switching along disease progression. In this review, we summarize current knowledge about the role of tissue-resident macrophages and recruited macrophages in pathogenesis of alcoholic liver disease (ALD), non-alcoholic steatohepatitis (NASH), viral hepatitis, and hepatocellular carcinoma (HCC).
AB - Hepatic macrophages are a remarkably heterogeneous population consisting of self-renewing tissue-resident phagocytes, termed Kupffer cells (KCs), and recruited macrophages derived from peritoneal cavity as well as the bone marrow. KCs are located in the liver sinusoid where they scavenge the microbe from the portal vein to maintain liver homeostasis. Liver injury may trigger hepatic recruitment of peritoneal macrophages and monocyte-derived macrophages. Studies describing macrophage accumulation have shown that hepatic macrophages are involved in the initiation and progression of various liver diseases. They act as tolerogenic antigen-presenting cells to inhibit T-cell activation by producing distinct sets of cytokines, chemokines, and mediators to maintain or resolve inflammation. Furthermore, by releasing regenerative growth factors, matrix metalloproteinase arginase, they promote tissue repair. Recent experiments found that KCs and recruited macrophages may play different roles in the development of liver disease. Given that hepatic macrophages are considerably plastic populations, their phenotypes and functions are likely switching along disease progression. In this review, we summarize current knowledge about the role of tissue-resident macrophages and recruited macrophages in pathogenesis of alcoholic liver disease (ALD), non-alcoholic steatohepatitis (NASH), viral hepatitis, and hepatocellular carcinoma (HCC).
KW - Kupffer cells
KW - alcoholic liver disease
KW - hepatic macrophages
KW - hepatocellular carcinoma
KW - non-alcoholic steatohepatitis
KW - viral hepatitis
KW - Disease Susceptibility
KW - Humans
KW - Immunophenotyping
KW - Liver Diseases/diagnosis
KW - Molecular Targeted Therapy
KW - Macrophages/drug effects
KW - Phenotype
KW - Cell Communication/genetics
KW - Kupffer Cells/immunology
KW - Biomarkers
KW - Disease Management
KW - Cytokines/metabolism
UR - http://www.scopus.com/inward/record.url?scp=85079335629&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079335629&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2019.03112
DO - 10.3389/fimmu.2019.03112
M3 - Review article
C2 - 32047496
AN - SCOPUS:85079335629
SN - 1664-3224
VL - 10
SP - 3112
JO - Frontiers in immunology
JF - Frontiers in immunology
M1 - 3112
ER -